162 related articles for article (PubMed ID: 10466881)
1. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study.
Schulte C; Dignass AU; Mann K; Goebell H
Scand J Gastroenterol; 1999 Jul; 34(7):696-702. PubMed ID: 10466881
[TBL] [Abstract][Full Text] [Related]
2. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
[TBL] [Abstract][Full Text] [Related]
5. Bone loss in patients with inflammatory bowel disease: a prospective study.
Roux C; Abitbol V; Chaussade S; Kolta S; Guillemant S; Dougados M; Amor B; Couturier D
Osteoporos Int; 1995 May; 5(3):156-60. PubMed ID: 7655175
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
8. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
9. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease.
Schulte C; Dignass AU; Mann K; Goebell H
Inflamm Bowel Dis; 1998 Nov; 4(4):268-75. PubMed ID: 9836078
[TBL] [Abstract][Full Text] [Related]
10. Genetic factors determine extent of bone loss in inflammatory bowel disease.
Schulte CM; Dignass AU; Goebell H; Röher HD; Schulte KM
Gastroenterology; 2000 Oct; 119(4):909-20. PubMed ID: 11040178
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
Ahmed SF; Horrocks IA; Patterson T; Zaidi S; Ling SC; McGrogan P; Weaver LT
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
[TBL] [Abstract][Full Text] [Related]
12. Bone density improves with disease remission in patients with inflammatory bowel disease.
Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
[TBL] [Abstract][Full Text] [Related]
13. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
14. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
Lamb EJ; Wong T; Smith DJ; Simpson DE; Coakley AJ; Moniz C; Muller AF
Aliment Pharmacol Ther; 2002 Nov; 16(11):1895-902. PubMed ID: 12390098
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
16. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
17. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
18. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
19. How activity of inflammatory bowel disease influences bone loss.
Orlic ZC; Turk T; Sincic BM; Stimac D; Cvijanovic O; Maric I; Tomas MI; Jurisic-Erzen D; Licul V; Bobinac D
J Clin Densitom; 2010; 13(1):36-42. PubMed ID: 20171567
[TBL] [Abstract][Full Text] [Related]
20. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]